Tactile Systems Technology, Inc., operating as Tactile Medical, is a medical technology company focused on developing and commercializing at-home medical devices for the treatment of chronic diseases. The company's business model centers on a direct-to-patient and direct-to-provider approach, generating revenue primarily through the sale and rental of its proprietary devices in the United States. Tactile Medical's product portfolio is divided into two main segments: lymphedema and airway clearance. The lymphedema segment, which accounts for over 80% of total revenue, features pneumatic compression devices such as the Flexitouch Plus, Entre Plus, and Nimbl systems. These devices are prescribed for the treatment of lymphedema, phlebolymphedema, lipedema, and chronic venous insufficiency. The airway clearance segment, representing the remainder of the company's revenue, is driven by the AffloVest, a portable, high-frequency chest wall oscillation vest used to treat patients with retained pulmonary secretions resulting from conditions like bronchiectasis and cystic fibrosis. The company also integrates digital health solutions into its offerings, such as the Kylee mobile application, which allows patients to track symptoms and share progress with healthcare providers. Tactile Medical's competitive position is supported by its extensive clinical evidence, a dedicated direct sales force, and established relationships with durable medical equipment (DME) partners and payers, including Medicare and the Veterans Administration. By focusing on at-home therapies, the company aims to improve patient quality of life while reducing the overall cost of care for the healthcare system.
